Understanding The Alpha2beta1 Integrin Receptor (P5759)

Target Name: Integrin alpha2beta1 (VLA-2) receptor

NCBI ID: P5759

Integrin alpha2beta1 (VLA-2) receptor

Other Name(s): alpha2beta1 integrin | VLA-2

Understanding The Alpha2beta1 Integrin Receptor

Integrin alpha2beta1 (VLA-2) receptor, also known as alpha2beta1 integrin, is a protein that is expressed in many different tissues throughout the body. It is a member of the integrin family, which is a group of transmembrane proteins that play a critical role in cell-cell and cell-extracellular matrix interactions.

The alpha2beta1 integrin receptor is involved in many different processes in the body, including cell adhesion, migration, and invasion. It is also involved in the regulation of the immune response and in the development of certain diseases, such as cancer.

Despite its importance, the alpha2beta1 integrin receptor has not yet been fully understood. little is known about its structure and function, and it is not clear what the best way to target it would be.

However, there is some research being done to investigate the alpha2beta1 integrin receptor, and it is possible that it may be a drug target or biomarker in the future.

One way to investigate the alpha2beta1 integrin receptor is through the use of techniques such as RNA interference and live cell imaging. These techniques can be used to reduce the level of the alpha2beta1 integrin receptor and visualize the effects on the cell.

Another way to study the alpha2beta1 integrin receptor is through the use of small molecules. Researchers have synthesized many different small molecules and are using them to investigate their ability to interact with the alpha2beta1 integrin receptor.

Some of the small molecules that have been shown to interact with the alpha2beta1 integrin receptor include inhibitors of tyrosine kinase, which are proteins that can modulate the activity of the alpha2beta1 integrin receptor.

Another way to study the alpha2beta1 integrin receptor is through the use of antibodies. Researchers have created antibodies that recognize the alpha2beta1 integrin receptor and are using them to study its structure and function.

While more research is needed, the alpha2beta1 integrin receptor is a promising drug target and biomarker. It is possible that it will be used in the future to treat a variety of diseases, including cancer.

Overall, the alpha2beta1 integrin receptor is a complex protein that is involved in many different processes in the body. While more research is needed, it is a promising drug target and biomarker that may be useful in the future in the treatment of a variety of diseases.

Protein Name: Integrin Alpha2beta1 (VLA-2) Receptor

The "Integrin alpha2beta1 (VLA-2) receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Integrin alpha2beta1 (VLA-2) receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets